“We look forward to presenting preclinical data at ASGCT that underscore the potential of our in vivo HSC engineering platform to address complex genetic disorders and cancer,” said Robert Peters, ...

The IT girls and guys of the Class of ’25 will finally be able to hack their HSC studies as authorities put the byte on outdated courses that still refer to floppy disks and Y2K. The final cohort of ...

BOSTON, April 29, 2025--(BUSINESS WIRE)--Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo therapies designed to precisely and durably engineer the ...